BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, February 16, 2026
Breaking News: BioWorld Science 2025 Year in Review
See today's BioWorld Science
Home
» Intron demonstrates inhibition of tumorigenesis using P18-BE3CRC in colorectal cancer organoid model
To read the full story,
subscribe
or
sign in
.
Cancer
Intron demonstrates inhibition of tumorigenesis using P18-BE3CRC in colorectal cancer organoid model
April 4, 2023
Intron Biotechnology Inc. has demonstrated the effectiveness of P18-BE3CRC using a cancer organoid model.
BioWorld Science
Microbiome
Organoids
Cancer